653 related articles for article (PubMed ID: 25426788)
1. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
[TBL] [Abstract][Full Text] [Related]
2. Significance of silver-stained nucleolar organizer regions in early diagnosis and prognosis of oral squamous cell carcinoma: a multivariate analysis.
Pillai KR; Sujathan K; Madhavan J; Abraham EK
In Vivo; 2005; 19(4):807-12. PubMed ID: 16001464
[TBL] [Abstract][Full Text] [Related]
3. Silver-binding nucleolar organizing regions: a study of oral leukoplakia and squamous cell carcinoma.
Chattopadhyay A; Chawda JG; Doshi JJ
Int J Oral Maxillofac Surg; 1994 Dec; 23(6 Pt 1):374-7. PubMed ID: 7699280
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of argyrophilic nucleolar organizer regions in oral tumor progression.
Spolidorio LC; Neves KA; Soares CP; Spolidorio DM; Basso MF; Malavazzi I; Almeida OP
Micron; 2002; 33(7-8):605-8. PubMed ID: 12475557
[TBL] [Abstract][Full Text] [Related]
5. Argyrophilic nucleolar organizer regions in inflammatory, premalignant, and malignant oral lesions: a quantitative and qualitative assessment.
Elangovan T; Mani NJ; Malathi N
Indian J Dent Res; 2008; 19(2):141-6. PubMed ID: 18445932
[TBL] [Abstract][Full Text] [Related]
6. Analysis of silver binding nucleolar organizer regions in exfoliative cytology smears of potentially malignant and malignant oral lesions.
Sowmya GV; Nahar P; Astekar M; Agarwal H; Singh MP
Biotech Histochem; 2017; 92(2):115-121. PubMed ID: 28296547
[TBL] [Abstract][Full Text] [Related]
7. Argyrophilic nucleolar organizer regions in the evaluation of tumour progression in the oral mucosa: correlation with tissue pathology.
Pillai KR; Sujathan K; Kannan S; Abraham EK; Mathew B; Amma NS; Nair MK; Menon VP
J Cancer Res Clin Oncol; 1994; 120(12):723-6. PubMed ID: 7798297
[TBL] [Abstract][Full Text] [Related]
8. The overexpression of p53 and proliferative activity in precancerous and cancerous lesions of oral squamous epithelium.
Ichikawa M; Ishii K; Nakajima T; Mogi K
J Exp Clin Cancer Res; 1997 Jun; 16(2):141-6. PubMed ID: 9261738
[TBL] [Abstract][Full Text] [Related]
9. AgNOR count as objective marker for dysplastic features in oral leukoplakia.
Chattopadhyay A; Ray JG; Caplan DJ
J Oral Pathol Med; 2002 Oct; 31(9):512-7. PubMed ID: 12269989
[TBL] [Abstract][Full Text] [Related]
10. The proliferative activity in oral epithelial dysplasia analyzed by proliferating cell nuclear antigen immunostaining and argyrophilic nucleolar organizer region staining.
Kobayashi I; matsuo K; Ozeki S; Ohishi M; Ishibashi Y; Sakai H
Hum Pathol; 1995 Aug; 26(8):907-13. PubMed ID: 7635453
[TBL] [Abstract][Full Text] [Related]
11. Comparing flow cytometric analysis and nucleolar organizer region enumeration in archival oral premalignant lesions.
Kahn MA; Mincer HH; Dockter ME; Hermann-Petrin JM
J Oral Pathol Med; 1993 Jul; 22(6):257-62. PubMed ID: 8355224
[TBL] [Abstract][Full Text] [Related]
12. Midkine expression in oral squamous cell carcinoma and leukoplakia.
Jham BC; Costa NL; Silva JM; de Miranda AC; Oliveira JC; Silva TA; Batista AC
J Oral Pathol Med; 2012 Jan; 41(1):21-6. PubMed ID: 21595751
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas.
Zoeller J; Flentje M; Sinn P; Born IA
Anal Cell Pathol; 1994 Jul; 7(1):77-88. PubMed ID: 7981138
[TBL] [Abstract][Full Text] [Related]
14. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
16. Quantification of AgNOR expression in exfoliated oral mucosal cells of tobacco chewers with and without lesion.
Sharma A; Saxena S
Indian J Dent Res; 2012; 23(2):251-6. PubMed ID: 22945719
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
18. Expression of Fas and Fas-ligand and analysis of argyrophilic nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis.
Guler N; Uckan S; Celik I; Oznurlu Y; Uckan D
Int J Oral Maxillofac Surg; 2005 Dec; 34(8):900-6. PubMed ID: 15907374
[TBL] [Abstract][Full Text] [Related]
19. Quantitative estimation of AgNORs in normal, dysplastic and malignant oral mucosa.
Chowdhry A; Deshmukh RS; Shukla D; Bablani D; Mishra S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):282-7. PubMed ID: 23446205
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
